Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9




Downlaod Files

   


Article Access statistics

Viewed: 1590

PDF Downloaded: 592


DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR SIMULTANEOUS ESTIMATION OF CILNIDIPINE AND VALSARTAN IN BULK AND TABLET DOSAGE FORM


Full Text PDF Share on Facebook Share on Twitter


Original Article

Author Details : Ritesh P. Bhole.Vinayak C. Pawara, Sohan S. Chitlange, Sager B. Wankhede

Volume : 2, Issue : 2, Year : 2015

Article Page : 102-107


Suggest article by email

Get Permission

Abstract

Cilnidipine and Valsartan in combined dosage form has been developed and validated. Sample and standard solutions of Cilnidipine and Valsartan were applied to precoated silica gel G 60 F254 HPTLC plates and the plates were developed with Toluene: Methanol: Ethyl acetate: Glacial Acetic acid in the ratio 8:1:1:0.1 (v/v/v/v) as mobile phase. The Rf value for cilnidipine and Valsartan was found to be 0.29 min and 0.56 min respectively. The detection was performed at 240 nm. The calibration curve was found to be linear between 1000 to 6000 ng/band for cilnidipine and 8-48 ?g/band for Valsartan with correlation coefficients 0.993 and 0.993 for Cilnidipine and Valsartan respectively. Accuracy and precision of the proposed method was evaluated by recovery studies (% recovery for Valsartan and Cilnidipine was 99.03 % and 99.86 %).The results have been validated statistically as per ICH guidelines.


Keywords: Validation, Valsartan, Cilnidipine, HPTLC



How to cite : Pawara R P B C, Chitlange S S, Wankhede S B, DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR SIMULTANEOUS ESTIMATION OF CILNIDIPINE AND VALSARTAN IN BULK AND TABLET DOSAGE FORM. Int J Pharm Chem Anal 2015;2(2):102-107


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.